QED improves customer access to products and services

Web upgrade streamlines the process of matching researchers with antibodies for their specific applications

QED Bioscience, Inc. has fostered more than two decades of sustained innovation by anticipating the needs of its customers.

The company's most recent initiative is a revamped interactive website that improves customer access to QED products and services. The new online presence at qedbio.com streamlines and secures the process of matching researchers with antibody products appropriate for their specific applications.

"Our main goal was to build a secure web marketplace that makes it easier for clients to find what they need and order online," said Eileen Skaletsky, President of QED. "The project was also an opportunity to upgrade our look and style, and we expect qedbio.com to continue evolving as the company's web presence grows."

In addition to an online catalog of more than 1,500 antibody products, instant order confirmation and tracking, Skaletsky said qedbio.com has the potential of becoming an online community "opening doors to discovery" as a source of breaking news, ideas, discussion and answers to key questions researchers face in the immunology universe.

"QED Bioscience has over 23 years of experience providing a wide variety of custom antibody services," said Eileen Skaletsky, President of QED "We are always seeking ways to improve the processes we use."

For more useful information about the latest developments at QED Bioscience, Inc., and a view from the leading edge of the research community, connect with the new qedbio.com.

-###-

About QED Bioscience, Inc.
QED Bioscience has been designing and manufacturing antibodies for over 20 years. Throughout the company's history, its goals have remained unchanged: provide the best antibody products and services on the market and support clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED. QED is located in San Diego, Calif., the single most important market worldwide for antibody engineering in preclinical research.